References
- Shah KM, Young LS. Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma. Clin Microbiol Infect 2009;15:982–988.
- Asano N, Yamamoto K, Tamaru J, . Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients. Blood 2009;113:2629–2636.
- Oyama T, Yamamoto K, Asano N, . Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin Cancer Res 2007;13:5124–5132.
- Rosenwald A, Wright G, Chan WC, . Lymphoma/Leukemia Molecular Profiling Project. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002;346:1937–1947.
- Oyama T, Ichimura K, Suzuki R, . Senile EBV + B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am J Surg Pathol 2003;27:16–26.
- Hofscheier A, Ponciano A, Bonzheim I, . Geographic variation in the prevalence of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a comparative analysis of a Mexican and a German population. Mod Pathol 2011;24:1046–1054.
- Hoeller S, Tzankov A, Pileri SA, . Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations. Hum Pathol 2010;41:352–357.
- Uner A, Akyurek N, Saglam A, . The presence of Epstein-Barr virus (EBV) in diffuse large B-cell lymphomas (DLBCLs) in Turkey: special emphasis on “EBV-positive DLBCL of the elderly”. APMIS 2011;119:309–316.
- Park S, Lee J, Ko YH, . The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood 2007;110:972–978.
- Xu FP, Liu YH, Zhuang HG, . [Clinicopathological features of Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly]. Zhonghua Bing Li Xue Za Zhi 2011;40:616–621.
- Kuze T, Nakamura N, Hashimoto Y, . The characteristics of Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma: comparison between EBV(+) and EBV(2) cases in Japanese population. Jpn J Cancer Res 2000;91:1233–1240.
- Gibson SE, Hsi ED. Epstein-Barr virus-positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotype. Hum Pathol 2009;40:653–661.
- Fu K, Weisenburger DD, Greiner TC, . Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood 2005;106:4315–4321.
- Hans CP, Weisenburger DD, Greiner TC, . Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004;103: 275–282.
- Wada N, Ikeda J, Hori Y, . Epstein-Barr virus in diffuse large B-cell lymphoma in immunocompetent patients in Japan is as low as in Western countries. J Med Virol 2011;83:317–321.
- Shimoyama Y, Yamamoto K, Asano N, . Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders: special references to lymphomas surrounding this newly recognized clinicopathologic disease. Cancer Sci 2008;99:1085–1091.
- Cho EY, Kim KH, Kim WS, . The spectrum of Epstein-Barr virus-associated lymphoproliferative disease in Korea: incidence of disease entities by age groups. J Korean Med Sci 2008;23:185–192.
- Li J, Zhang XS, Xie D, . Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression. Cancer Biol Ther 2007;6:1997–2004.
- Chen JN, Ding YG, Feng ZY, . Association of distinctive Epstein-Barr virus variants with gastric carcinoma in Guangzhou, southern China. J Med Virol 2010;82:658–667.
- Adam P, Bonzheim I, Fend F, . Epstein-Barr virus-positive diffuse large B-cell lymphomas of the elderly. Adv Anat Pathol 2011; 18:349–355.
- Nakamura S, Jaffe ES, Swerdlow SH.EBV + diffuse large B-cell of the elderly. In: Swerdlow SH, Campo E, Harris NL, et al. editors. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. pp. 243–244.
- Morales D, Beltran B, De Mendoza FH, . Epstein-Barr virus as a prognostic factor in de novo nodal diffuse large B-cell lymphoma. Leuk Lymphoma 2010;51:66–72.
- Castillo JJ, Beltran BE, Miranda RN, . Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: what we know so far. Oncologist 2011;16:87–96.
- Kojima M, Sugiura I, Itoh H, . Histological varieties of Epstein-Barr virus-related lymph node lesion resembling autoimmune disease-like clinicopathological findings in middle-aged and elderly patients: a study of six cases. Pathol Res Pract 2006;202:609–615.
- Borza CM, Hutt-Fletcher LM. Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med 2002;8:594–599.
- Thompson MP, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res 2004;10:803–821.
- Rezk SA, Weiss LM. Epstein-Barr virus-associated lymphoproliferative disorders. Hum Pathol 2007;38:1293–1304.
- Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 2004;350: 1328–1337.
- Kitai R, Matsuda K, Adachi E, . Epstein-Barr virus-associated primary central nervous system lymphoma in the Japanese population. Neurol Med Chir (Tokyo) 2010;50:114–118.